Urol. praxi, 2015; 16(1): 12-15

Testosterone replacement treatment in hypogonadal men

MUDr.Otakar Štanc
Urologické oddělení, Nemocnice Na Bulovce, Praha

This article aims to highlight the current recommendations and options for androgen replacement therapy in the Czech Republic, especially

in late-onset hypogonadism. It describes the basics of diagnosis, treatment and monitoring of hypogonadal men based on the

current recommendations of international scientific societies.

Keywords: hypogonadism, replacement therapy, testosterone

Published: March 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Štanc O. Testosterone replacement treatment in hypogonadal men. Urol. praxi. 2015;16(1):12-15.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zámečník L. Praktická andrologie dospělých. Praha : Mladá Fronta, 2010: 50.
    2. Crawford ED, et al. The association of time of day and serum testosterone concentration in a large screening population. BJU International. 6. Jun 2007; 100(3): 509-513. Go to original source... Go to PubMed...
    3. Kawaciuk I. Substituce testosteronu u stárnoucích hypogonadálních mužů. Interní med. 2002; 1: 7-9.
    4. Isidori AM, Greco EA, Aversa A. Androgen deficiency and hormone replacement therapy. BJU International. 2005; (96): 212-216. Go to original source... Go to PubMed...
    5. Pühse G, Secker A, Kemper S, Hertle L, Kliesch S. Testosterone deficiency in testicular germ-cell cancer patientes is not influenced by oncological treatment. Int J Androl. 2011; 34(5 Pt2): e351-357. Go to original source...
    6. Kulkarni ML, Balaji MD, Kulkarni AM, Sushanth S, Kulkarni BM. Kallmann's syndrome. Indian J Pediatr. 2007; 74(12): 1113-1115. Go to original source... Go to PubMed...
    7. FC Wu A, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010; 363: 123-135. Go to original source... Go to PubMed...
    8. Saad F, et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. Eur J Endocrinol. November 2011; 165(5): 675-685. Go to original source...
    9. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. Journal of Clinical Endocrinology and Metabolism. 2006; 91: 4335-4343. Go to original source... Go to PubMed...
    10. Lunenfeld B, Saad F, Hoesl CE. ISA, ISSAM and EAU recommendation for the investigation, tratment and monitoring of late-onset hypogonadism in males. Aging Male. 2005; 8, 2: 59-74. Go to original source... Go to PubMed...
    11. Kubíček V. Substituční terapie androgeny. Via pract. 2009; 6(5): 211-214.
    12. Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur. Urol. 2009; 55(1): 121-130. Go to original source... Go to PubMed...
    13. Algarte-Genin M, Cussenot O, Costa P. Prevention of prostate conceer by androgens: experimental paradox or clinical reality. Eur Urol. 2004; 46: 285-294. Go to original source... Go to PubMed...
    14. Ko YH, Moon DG, Du Geon, Moon KH. Testosterone Replacement Alone for Testosterone Deficiency Syndrome Improves Moderate Lower Urinary Tract Symptoms: One Year Follow-Up. J Mens Health. 2013; 31(1): 47-52. Go to original source... Go to PubMed...
    15. Hanafy HM. Testosterone therapy and obstructive sleep apnea: is there a real connection? J Sex Med. 2007; 4, 5: 1241-1246. Go to original source... Go to PubMed...
    16. Shabsigh A, et al. Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med. 2005; 2, 5: 716-721. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.